Skip to content

Oral Health Status Screening of Adults in Mumbai

Evaluation of Oral Health Status of an Adult Population in Mumbai - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108132
Enrollment
500
Registered
2026-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K039- Disease of hard tissues of teeth,unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Colgate-Palmolive
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Males and Females, between 18-65 years of age; Informed Consent Form signed and availability for the duration of the study; Good general health (absence of any condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve/hip replacements, etc.) Willingness to provide information related to their medical history Minimum of 10 uncrowned permanent natural teeth (excluding wisdom teeth)

Exclusion criteria

Exclusion criteria: Hepatitis B or C, HIV infection, oral herpes (cold sore), sinusitis, etc., based on self-reported medical history; Premedication required for dental procedures; Current or history of infectious disease (i.e. Current contagious illness, upper respiratory infections) based on self-reported medical history; Oral pathology, chronic disease, or a history of allergy to oral care products, teeth whitening products, hydrogen peroxide, personal care consumer products, or their ingredients; Wearing removable retainers, dentures or with fixed orthodontic appliances; Obvious signs of periodontal disease, rampant caries, or any condition that the dental examiner considers exclusionary from the study; Using anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study; Participating in any other clinical study that might interfere with the main study outcome; Pregnant or breastfeeding; Ongoing use of medications known to affect the gum tissues (i.e. calcium channel blockers, phenytoin, cyclosporine); Use of antibiotics any time during or three months prior to entry into the study. Use of therapeutic oral care products within 1 month prior to entry into the study. Abnormal salivary function including medication induced dry mouth Five (5) or more decayed untreated dental sites at screening Active periodontal disease (ie purulent exudate or tooth mobility), or having received periodontal treatment (ex: SRP- scaling and root planing) 6 months before entering study

Design outcomes

Primary

MeasureTime frame
General health status Oral health status Oral hygiene practices Microbiome characterization Timepoint: Single time point (baseline)

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Bhuvana Gurumurthy

Colgate-Palmolive India Limited

bhuvana_gurumurthy@colpal.com02267096165

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026